Reversal of immunosuppression in cutaneous T cell lymphoma by anti-CTLA-4 antibody

被引：0
|
作者：
Berger, C. L. [1 ]
Girardi, M. [1 ]
Tigelaar, R. [1 ]
Edelson, R. L. [1 ]
机构：
[1] Yale Univ, New Haven, CT USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2007年 / 127卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
698
引用
收藏
页码：S117 / S117
页数：1
相关论文
共 50 条
  • [31] Potent inhibition of CTLA-4 expression by an anti-CTLA-4 ribozyme
    Cepero, E
    Hnatyszyn, HJ
    Kraus, G
    Lichtenheld, MG
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 247 (03) : 838 - 843
  • [32] The microbial metabolite desaminotyrosine enhances T-cell priming and cancer immunotherapy with anti-CTLA-4
    Joachim, L.
    Goettert, S.
    Sax, A.
    Steiger, K.
    Neuhaus, K.
    Kleigrewe, K.
    Thiele-Orberg, E.
    Heidegger, S.
    Poeck, H.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 53 - 53
  • [33] A novel anti-CTLA-4 antibody with potent anti-tumor activity emerged using humanized CTLA-4 mouse model
    Guo, Chaoshe
    Yang, Yi
    Li, Zhihong
    Li, Yanan
    Chen, Yunyun
    CANCER RESEARCH, 2020, 80 (16)
  • [34] The role of regulatory T cells in the anti-tumor activity of anti-CTLA-4 antibodies
    Thierry, Kevin
    Menetrier-Caux, Christine
    M S-MEDECINE SCIENCES, 2020, 36 (01): : 73 - 76
  • [35] A CD4 T cell predominant dermatitis in stage IV melanoma patients treated with anti-CTLA-4 monoclonal antibody as a single agent.
    Jaber, S
    Cowen, E
    Haworth, L
    Booher, S
    Berman, D
    Rosenberg, S
    Hwang, S
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2005, 124 (04) : A37 - A37
  • [36] A humanized, high affinity anti-CCR4 antibody for immunotherapy of cutaneous T cell lymphoma and characterization on T cell function
    Chang, DeKuan
    Han, Thomas
    Clark, Rachael A.
    Zhu, Quan
    Kupper, Thomas S.
    Marasco, Wayne A.
    CANCER RESEARCH, 2013, 73 (08)
  • [37] Screening and antitumor effect of an anti-CTLA-4 nanobody
    Wan, Ruirong
    Liu, Aiqun
    Hou, Xiaoqiong
    Lai, Zongqiang
    Li, Jieping
    Yang, Nuo
    Tan, Juntao
    Mo, Fengzhen
    Hu, Zixi
    Yang, Xiaomei
    Zhao, Yongxiang
    Lu, Xiaoling
    ONCOLOGY REPORTS, 2018, 39 (02) : 511 - 518
  • [38] Selective depletion of human activated T cell by anti-CTLA-4 human scFv-perforin immunotoxin
    Lu, XF
    Zeng, LY
    Li, SF
    Huang, Q
    Chen, LH
    Wan, L
    Lu, XF
    XENOTRANSPLANTATION, 2005, 12 (05) : 405 - 406
  • [39] Anti-CTLA-4 therapy broadens the melanoma-reactive CD8+ T cell response
    Kvistborg, Pia
    Philips, Daisy
    Kelderman, Sander
    Hageman, Lois
    Ottensmeier, Christian
    Joseph-Pietras, Deborah
    Welters, Marij J. P.
    van der Burg, Sjoerd
    Kapiteijn, Ellen
    Michielin, Olivier
    Romano, Emanuela
    Linnemann, Carsten
    Speiser, Daniel
    Blank, Christian
    Haanen, John B.
    Schumacher, Ton N.
    SCIENCE TRANSLATIONAL MEDICINE, 2014, 6 (254)
  • [40] Role of anti-CTLA-4 therapies in the treatment of cancer
    Abrams, SI
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2004, 6 (01) : 71 - 77
12345